Science Explorer Back to mapMap
Discussion
Researcher · Instituto Nacional de Cardiología · Mexico

Mary‐Carmen Amigo

Mary‐Carmen Amigo publishes mostly in Rheumatology, Hematology and Pulmonary and Respiratory Medicine, on topics such as Systemic Lupus Erythematosus Research, Systemic Sclerosis and Related Diseases and Rheumatoid Arthritis Research and Therapies.

ORCID 0000-0002-2255-3138 OpenAlex
World rank
#602,364
of 7,710,434 ranked researchers
Rank in Mexico
#1,157
of 55,557
Works
94
Citations
4k
Citations per work
42.3
h-index
32
i10-index 49Top 9.3% in Rheumatology
Mary‐Carmen Amigo

What does Mary‐Carmen Amigo research?

Mary‐Carmen Amigo's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 57 works · 60.4% of their workMedicine: 57 works · 60.4% of their workRheumatology: 31 works · 33.1% of their workHematology: 7 works · 7.8% of their workPulmonary and Respiratory Medicine: 7 works · 7.8% of their workPathology and Forensic Medicine: 7 works · 7.0% of their workHepatology: 4 works · 4.7% of their workEverything else: 33 works · 35.3% of their workLife Sciences: 4 works · 4.3% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 4.3% of their workGenetics: 4 works · 4.3% of their workTHEIR WORKMary‐Carmen Amigo94works
Life Sciences4%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5760.4%
  2. Everything else3335.3%
    1. Biochemistry, Genetics and Molecular Biology44.3%
  1. 1Rheumatology33% of their works
  2. 2Hematology8% of their works
  3. 3Pulmonary and Respiratory Medicine8% of their works
  4. 4Pathology and Forensic Medicine7% of their works
  5. 5Hepatology5% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Mary‐Carmen Amigo's research?

The keywords of their largest research topics: Autoantibodies, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Inflammation, Immunosuppressive Therapy, Cytokines, Fibrosis and Systemic Sclerosis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Autoantibodies973 topics
  2. Antiphospholipid Syndrome721 topic
  3. Systemic Lupus Erythematosus721 topic
  4. Inflammation283 topics
  5. Immunosuppressive Therapy212 topics
  6. Cytokines182 topics
  7. Fibrosis131 topic
  8. Systemic Sclerosis131 topic
  9. Biological Therapy121 topic
  10. Rheumatoid Arthritis121 topic
  11. Glomerular Diseases101 topic
  12. Nephrotic Syndrome101 topic
  13. Platelets101 topic
  14. Thrombosis101 topic
  15. Autoimmune Hepatitis81 topic
  16. Primary Biliary Cirrhosis81 topic
  17. ANCA-associated61 topic
  18. Atherosclerosis61 topic
  19. Immune Response61 topic
  20. Vasculitides61 topic

Where does Mary‐Carmen Amigo work?

Mary‐Carmen Amigo's main affiliation in the publication record is Instituto Nacional de Cardiología, Mexico.

How many publications and citations does Mary‐Carmen Amigo have?

OpenAlex counts 94 works and 3,979 citations for Mary‐Carmen Amigo, an h-index of 32, ranking #602,364 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mary‐Carmen Amigo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.